Longevity
SS-31
Metabolic
0
Amino acids
Molecular weight
Peptide
Type
SS-31 (Elamipretide) is an aromatic-cationic tetrapeptide that selectively binds to cardiolipin in the inner mitochondrial membrane, preventing lipid peroxidation and optimizing electron transport chain function for enhanced cellular energy production.
Selectively binds to cardiolipin in inner mitochondrial membrane, preventing lipid peroxidation and optimizing electron transport chain function. This improves ATP production and reduces oxidative damage at the mitochondrial level.
Reconstituted: 2-8°C in amber/dark vials, use within 30 days. Light sensitive
Once daily (morning or pre-workout for athletic use)
5-10mg general support, 10-40mg clinical/performance protocols
4-12 weeks for therapeutic protocols
No visual available
Due to this peptide having no amino acids, there is no molecular chain to display.
Directly protects mitochondria
Improves cellular energy production (ATP)
Reduces oxidative damage
Enhances exercise capacity
Excellent safety profile in clinical trials
Cardioprotective effects
This peptide is still gaining traction in the community.
Mitochondrial-Targeted Peptide | Cardiolipin Protector
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of SS-31.
Subcutaneous or intravenous injection. SS-31 dissolves readily and should be protected from light due to photosensitivity.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| General mitochondrial support | 5 | 1 week range | SubQ |
| Athletic performance | 10 | 1 week range | SubQ |
| Clinical protocols | 40 | 1 week range | SubQ or IV |
| Acute cardioprotection | 0.25 | — | IV |
Materials needed:
Steps to reconstitute
The SS-31 Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
SS-31
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg SS-31 vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of SS-31 interactions with other common peptides and substances.
Healing
bpc
Longevity
COMPATIBLE
BPC-157 focuses on tissue repair while SS-31 targets cellular energetics.
Longevity
mot
Metabolic
SYNERGISTIC
Both are mitochondrial peptides with complementary mechanisms.
Longevity
nad
Metabolic
SYNERGISTIC
Both support mitochondrial function through different mechanisms.
Healing
thymos
Longevity
COMPATIBLE
Both cardioprotective via different pathways.
Known hypersensitivity to peptides
Pregnancy or breastfeeding (limited data)
Severe injection site reactions
Allergic reaction signs (rash, breathing difficulty)
Unusual fatigue or weakness (paradoxical reaction)
Cardiovascular symptoms
Severe headaches or vision changes
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
SS-31 is a well studied compound
SS-31
SS-31 is a well studied compound
Primary Mitochondrial Myopathy Phase 2 Trial
40mg daily for 12 weeks in 36 patients showed significant improvements in 6-minute walk test and fatigue scores with excellent safety profile.
2018
Cardioprotection in Heart Failure Study
0.25mg/kg/hr infusion during cardiac surgery reduced cardiac injury markers and improved mitochondrial function.
2019
Age-Related Muscle Dysfunction Study
8 weeks in aged mice reversed age-related decline in muscle function, increased ATP production, and reduced oxidative stress.
2020
Barth Syndrome Clinical Trial
Phase 3 trial with 40mg daily for 48 weeks showed trends toward cardiac improvement in this rare mitochondrial disorder.
2021